Bio Rad实验室(usBIO)-基本信息-阿布量化

来自 : 发布时间：2024-09-20

Bio-Rad Laboratories制造和销售生命科学研究、医疗保健、分析化学和其它市场使用于分离复杂化学制品和生物材料辨认、分析和净化成分产品，产品供应到大学和医学院实验室、配药和生物工艺公司、食物测试的实验室，以及政府和产业研究设施。Bio Rad实验室分为2个部分来运作：生命科学（Life Science）和临床诊断（Clinical Diagnostics）。1、生命科学集团：开发、制造并提供一系列广泛的实验室仪器、设备、耗材和试剂，应用于功能基因组学、蛋白质组学、药物研发和生产、细胞生物学、食品安全领域以及研究和科学教育领域，该集团位列全球五大生命科学公司治疗，以质量和创新而著称。该部分的产品是基于分离、纯化、识别、分析、放大生物材料（如：蛋白质，核酸，细胞和细菌）技术而研发的。技术和应用包括：电泳、成像、多重免疫测定、层析法、微生物学、生物信息学、蛋白质功能分析、转染、流式细胞术、扩增、以及实时和数字PCR。Bio-Rad公司为世界各地的实验室研究提供产品和技术服务支持。2、临床诊断集团：为为医疗检查和诊断领域提供产品研发、制造、销售和支持。Bio-Rad公司是一家领先的专业诊断公司，其糖尿病监测和质量控制系统是行业公认的黄金标准。Clinical Diagnostics Group的血液病毒的检测、血型检测、自身免疫疾病和遗传疾病的测试，以及基于因特网的软件产品也是行业内众所周知的。Bio-Rad公司的临床诊断产品包括广泛的用于检测、识别以及体液和组织的物质量化技术，其结果被用作协助以支持医疗诊断、检测、评价、以及疾病和其他医疗状况的监测和治疗。Bio Rad实验室(伯乐生命医学产品公司)Bio-Rad Laboratories(BIO)历史沿革： 1952年，David Schwartz和他的妻子Alice Schwartz创立了Bio-Rad Laboratories； 1967年，Bio Rad实验室进入临床检测领域； 1970年代晚期到1980年代，Bio-Rad Laboratories通过收购进入了分析测试仪器系统领域； 1999年，Bio Rad实验室收购了Pasteur Sanofi Diagnostics，增强了公司在艾滋病毒及其他传染病毒诊断产品市场地位； 2000年，Bio-Rad Laboratories剥离其半导体业务； 2004年，Bio Rad实验室剥离其光电计量及共聚焦显微镜产品业务； 2007年末，Bio-Rad Laboratories收购瑞士DiaMed Holding AG，增强了其在免疫血液学市场地位； 2013年1月，Bio Rad实验室收购AbD Serotec（MorphoSys AG的一个部门）。交易日期 交易人 职位 类型 交易份额 价格 2019-05-15 Ernst (Timothy Scott) General Counsel Sell 192 299.12 2019-05-15 Ernst (Timothy Scott) General Counsel Sell 309 299.31 2019-05-14 Magni (Giovanni) Officer Buy 3500 74.27 2019-05-14 Ernst (Timothy Scott) General Counsel Sell 345 290.00 2019-05-14 Magni (Giovanni) Officer Sell 1803 290.63 2019-05-12 Schwartz (Norman D) Chief Executive Officer Buy 37000 75.38 2019-05-12 Schwartz (Norman D) Chief Executive Officer Sell 22833 296.28 2018-12-13 Tsingos (Christine A) Chief Financial Officer Sell 1411 248.00 2018-12-11 Stark James R Officer Sell 848 254.77 2018-12-10 Tumolo (Annette) Officer Buy 1200 159.32 2018-12-10 Tumolo (Annette) Officer Sell 1176 254.00 2018-12-10 Tumolo (Annette) Officer Sell 1200 255.00 2018-12-09 Schwartz (Steven D) Beneficial Owner of More than 10% Class Gift 54 -- 2018-12-09 Schwartz (Steven D) Beneficial Owner of More than 10% Class Gift 54 -- 2018-12-09 Schwartz (Norman D) Chief Executive Officer Gift 54 -- 2018-12-09 Schwartz (Alice N) Director and Beneficial Owner Gift 324 -- 2018-12-09 Schwartz (Alice N) Director and Beneficial Owner Gift 3970 -- 2018-12-09 Schwartz (Norman D) Chief Executive Officer Gift 54 -- 2018-09-10 Tumolo (Annette) Officer Buy 1000 -- 2018-09-10 Stark James R Officer Buy 500 -- 2018-09-10 Schwartz (Norman D) Chief Executive Officer Sell 2877 308.37 2018-09-10 Crowley (Michael) Officer Sell 339 308.37 2018-09-10 Hutton Ronald W Officer and Treasurer Sell 104 308.37 2018-09-10 Hertia John Officer Buy 1300 -- 2018-09-10 Tumolo (Annette) Officer Sell 347 308.37 机构持股 持有者 持有份额 持股比例 份额变化 变化率 报告日期 AQR Capital Management LLC 247192 0.83% 76072 44.46% 2019-03-31 Levin Easterly Partners LLC 586617 1.97% 17412 3.06% 2019-03-31 Wells Fargo Co 629750 2.11% -16375 -2.53% 2019-03-31 Boston Mgmt Research (MA ) 636514 2.14% -- -- 2019-07-31 Atlanta Capital Management Company,LLC 750113 2.52% 1093 0.15% 2019-03-31 American Century Companies Inc 788955 2.65% 100850 14.66% 2019-03-31 BlackRock Fund Advisors 1092478 3.67% 261 0.02% 2019-07-31 Vanguard Group Inc 1915248 6.43% 29183 1.55% 2019-03-31 BlackRock Inc 1928542 6.47% -7466 -0.39% 2019-03-31 Vanguard Investments Australia Ltd 580910 1.95% 79 0.01% 2019-07-31 Acadian Asset Management LLC 513409 1.72% 192296 59.88% 2019-03-31 State Street Corporation 489630 1.64% 19863 4.23% 2019-03-31 Polar Capital LLP 249639 0.84% -1150 -0.46% 2019-03-31 Wells Fargo Funds Management LLC 294422 0.99% -6633 -2.20% 2019-07-31 Bank of America Corporation 321795 1.08% 34592 12.04% 2019-03-31 AllianceBernstein L.P. 366874 1.23% 125940 52.27% 2019-03-31 Transamerica Asset Management, Inc 374306 1.26% 2582 0.69% 2019-07-31 Westfield Capital Management Company, LP 376471 1.26% 453 0.12% 2019-03-31 UBS Asset Mgmt Americas Inc 386688 1.30% -28125 -6.78% 2019-03-31 Millennium Management LLC 420874 1.41% 22546 5.66% 2019-03-31 BlackRock Asset Management Canada Ltd 2374585 7.96% 432 0.02% 2019-05-31 Geode Capital Management, LLC 428376 1.44% 229745 115.66% 2018-12-31 Bank of New York Mellon Corp 270927 0.91% 270927 -- 2018-12-31 Fisher Asset Management, LLC 258795 0.87% 2443 0.95% 2018-12-31 Levin Capital Strategies, L.P. 569205 1.90% 561328 7126.16% 2018-12-31 TimesSquare Capital Management, LLC 611335 2.04% 89350 17.12% 2018-12-31 Ariel Investments, LLC 232661 0.78% 685 0.30% 2018-09-30 Federated Investors Inc 237562 0.79% 226667 2080.47% 2018-09-30 SPDR State Street Global Advisors 227635 0.76% -9013 -3.81% 2018-11-30 Fidelity Management Research Company 407988 1.36% -286516 -41.25% 2018-11-30 Wells Capital Management Inc. 363442 1.21% -20068 -5.23% 2018-09-30 BlackRock Institutional Trust Company NA 655231 2.19% -31888 -4.64% 2018-06-30 American Century Investment Management, Inc 687559 2.29% -4098 -0.59% 2018-09-30 Renaissance Technologies Corp 303000 1.01% -40700 -11.84% 2018-06-30 Fort Washington Investment Advisors Inc 290173 0.97% -22639 -7.24% 2018-06-30 Eaton Vance Management 1573235 5.28% -302107 -16.11% 2017-12-31 American Century Inv Mgt Inc 691657 2.32% -10709 -1.52% 2018-06-30 State Street Corp 506658 1.70% -28320 -5.29% 2018-06-30 Managed Account Advisors LLC 315363 1.06% -13213 -4.02% 2018-06-30 Putnam Investment Management,LLC 260742 0.87% 123871 90.50% 2018-06-30 AllianceBernstein LP 257447 0.86% -74670 -22.48% 2018-06-30 State Street Global Markets, LLC 233802 0.78% -2071 -0.88% 2018-07-31 Polar Asset Management Partners 304356 1.02% 139566 84.69% 2018-03-31 NWQ Investment Management Co LLC 257083 0.86% -30493 -10.60% 2017-12-31 Hitchwood Capital Management LP 350000 1.18% -50000 -12.50% 2017-09-30 Samlyn Capital, LLC 219319 0.74% 104335 90.74% 2017-12-31 Citadel Advisors Llc 214494 0.72% 29910 16.20% 2017-09-30 Epoch Investment Partners Inc 249904 0.84% 24420 10.83% 2017-09-30 Cramer Rosenthal McGlynn, LLC 277294 0.93% -41648 -13.06% 2017-09-30 Manufacturers Life Insurance Co 230092 0.78% -74805 -24.53% 2017-06-30 Dimensional Fund Advisors, Inc. 276843 0.94% 6685 2.47% 2016-09-30 Credit Suisse First Boston (CSFB) 320422 1.08% 87664 37.66% 2016-09-30 Hermes Fund Managers (Singapore) Pte. Limited 311712 1.06% 43280 16.12% 2016-12-31 Morgan Stanley Co Inc 455240 1.54% 302006 197.09% 2016-09-30 Corvex Management LP 487254 1.65% -- -- 2016-09-30 Alice N. Schwartz 2807223 3.00% 371872831 0.10% 1999-11-30 共同基金持股 持有者 持有份额 持股比例 份额变化 变化率 报告日期 iShares US Medical Devices ETF 86977 0.29% 548 0.63% 2019-07-30 Vanguard Extended Market Index Fund 274103 0.92% -3171 -1.14% 2019-06-30 Vanguard Small Cap Growth Index Fund 308011 1.03% -4953 -1.58% 2019-06-30 Transamerica Large Cap Value Fund 357500 1.20% 2500 0.70% 2019-06-30 Vanguard Small Cap Index 538125 1.81% -13106 -2.38% 2019-06-30 UBS: Global Equity-UBS 562075 1.89% -- -- 2019-03-31 Vanguard Total Stock Market Index Fund 576140 1.93% 107 0.02% 2019-06-30 iShares Core S P Mid-Cap ETF 588702 1.98% 1140 0.19% 2019-07-30 Eaton Vance Atlanta Capital SMID-Cap Fd 636514 2.14% -- -- 2019-06-30 SPDR 228120 0.77% -3024 -1.31% 2019-06-30 Polar Capital Healthcare Opps Fund 196951 0.66% -- -- 2019-06-30 iShares S P Mid-Cap 400 Growth ETF 172897 0.58% -- -- 2019-07-30 State Street Russell Small/Mid Cap 91513 0.31% -- -- 2019-07-31 Fidelity 95829 0.32% -1041 -1.07% 2019-06-30 ClearBridge Mid Cap Fund 104000 0.35% -- -- 2019-06-30 Wells Fargo Discovery Fund 104800 0.35% -3000 -2.78% 2019-06-30 T. Rowe Price QM US Small-Cap Gr Eq Fd 108800 0.37% -- -- 2019-06-30 Wells Fargo Opportunity Fund 114503 0.38% -- -- 2019-06-30 Ariel Fund 115381 0.39% -- -- 2019-06-30 State Street S P Mid Cap Index Fund 122581 0.41% -1500 -1.21% 2019-07-31 Pictet TR - Divers Alpha 167574 0.56% 19977 13.53% 2019-05-31 First Trust Health Care AlphaDEX 88950 0.30% -- -- 2019-06-27 iShares Core MSCI AllCntry Wld exCan ETF 586809 1.97% -- -- 2019-05-23 iShares S P US Mid-Cap ETF 586581 1.97% -- -- 2019-05-30 iShares S P US Mid-Cap ETF (CAD-Hedged) 586581 1.97% -- -- 2019-05-30 iShares Core S P US Total Market ETF 586581 1.97% -- -- 2019-05-30 Vanguard Small Cap Index Fund 551491 1.85% 3481 0.64% 2019-04-30 EATON VANCE SMALL-CAP FUND 636514 2.12% -- -- 2018-12-31 EARNEST Md-Cap-UBS 77000 0.26% -- -- 2018-12-31 EARNEST Partners Mid Cap Core Wrap 77000 0.26% -- -- 2018-12-31 AMG TimesSquare Mid Cap Growth Fund 117400 0.39% -800 -0.68% 2018-12-31 Putnam Sustainable Leaders Fund 74700 0.25% 3700 5.21% 2018-09-30 Wells Fargo Opportunity A 120907 0.41% -9815 -7.51% 2018-07-31 Putnam Multi-Cap Growth A 71000 0.24% -- -- 2018-06-30 Principal MidCap S P 400 Index SP 71603 0.24% 451 0.63% 2018-07-31 Neuberger Berman Mid Cap Growth Inv 72500 0.24% -- -- 2018-07-31 Touchstone Focused Y 93001 0.31% -9153 -8.96% 2018-06-30 Eaton Vance Atlanta Capital SMID-Cap I 1231302 4.13% -- -- 2018-07-31 Vanguard Total Stock Mkt Idx 526462 1.76% 2928 0.56% 2018-07-31 Vanguard Small Cap Growth Index Inv 301008 1.01% 3601 1.21% 2018-07-31 Vanguard Extended Market Idx Inv 268534 0.90% 5000 1.90% 2018-07-31 iShares S P Mid-Cap 400 Growth 177605 0.56% 1757 1.00% 2018-09-12 Wells Fargo Discovery Admin 118500 0.40% -- -- 2018-07-31 Ariel Fund Investor 123381 0.41% -7100 -5.44% 2018-06-30 Fidelity Spartan 91371 0.31% -- -- 2018-07-31 T. Rowe Price QM US Small-Cap Growth Eq 97300 0.33% 6600 7.28% 2018-06-30 AMG TimesSquare Mid Cap Growth Instl 107600 0.36% -- -- 2018-07-31 iShares US Medical Devices 113845 0.36% 422 0.37% 2018-09-12 ClearBridge Mid Cap A 115000 0.39% -- -- 2018-07-31 Franklin Balance Sheet Investment Fund A 64928 0.22% -- -- 2018-06-30 AB Global Thematic Growth A 75400 0.25% -- -- 2018-05-31 iShares Russell Mid-Cap Value 64256 0.23% -- -- 2018-06-21 iShares Russell 1000 Value 66400 0.23% 20 0.03% 2018-06-21 Fidelity Advisor 69000 0.23% -3000 -4.17% 2018-02-28 CREF Stock R1 64618 0.22% -817 -1.25% 2018-02-28 State Street Russell Small/Mid Cap Idx Fd Cl I 69278 0.23% 1700 2.52% 2017-06-30 Vanguard Small Cap Value Index Inv 293022 0.99% 11019 3.91% 2016-12-31 Ariel Appreciation Investor 137825 0.47% -36300 -20.85% 2016-12-31 Vanguard Explorer Inv 142140 0.48% -19000 -11.79% 2016-09-30 iShares S P Mid-Cap 400 Value 86426 0.29% 208 0.24% 2017-02-07 Vanguard Global Equity Inv 81244 0.28% 6446 8.62% 2016-09-30 Wells Fargo Advantage Opportunity Fund 257615 0.90% -6584 -2.50% 2015-09-30 Vanguard Small Cap Value Index Fund 227049 0.80% 3585 1.60% 2015-10-31 SPDR® S P MIDCAP 400 ETF 202100 0.70% -1666 -0.80% 2015-09-30 Touchstone Focused Fund 198950 0.70% 3635 1.90% 2015-09-30 Transamerica Large Cap Value 189894 0.60% -7849 -4.00% 2015-09-30 Vanguard Explorer Fund 180240 0.60% -- -- 2015-09-30 Ariel Appreciation Fund 174125 0.60% -40600 -18.90% 2015-09-30 Royce Pennsylvania Mutual 147112 0.50% -14580 -9.00% 2015-09-30 SSgA - S P Mid-Cap Index Strategy Tr 134887 0.50% -- -- 2015-06-30 iShares Core S P Mid-Cap (AU) 360558 1.20% 485 0.10% 2015-11-19 Ronald W. Hutton Presently, Ronald W. Hutton occupies the position of Treasurer Vice President at Bio-Rad Laboratories, Inc. Mr. Hutton previously occupied the position of Treasury Director at DCO Management LLC. Jeffrey L. Edwards Currently, Jeffrey L. Edwards occupies the position of Chief Financial Officer, Director Vice President at Serica Technologies, Inc. He is also on the board of 6 other companies. Mr. Edwards previously held the position of Chief Financial Officer EVP-Business Development at Allergan, Inc., Principal at Security Pacific National Bank and Principal at Banque Paribas Belgique SA. Mr. Edwards received an undergraduate degree from Muhlenberg College. Alice N. Schwartz Alice N. Schwartz founded Bio-Rad Laboratories, Inc. Ms. Schwartz is on the board of Bio-Rad Laboratories, Inc. In the past she held the position of Research Associate at the University of California. James R. Stark James R. Stark occupies the position of Vice President Controller of Bio-Rad Laboratories, Inc. Christine A. Tsingos Ms. Christine A. Tsingos is an Independent Director at Varex Imaging Corp., an Independent Director at Nanometrics, Inc. and a Chief Financial Officer Executive Vice President at Bio-Rad Laboratories, Inc. She is on the Board of Directors at Varex Imaging Corp. and Nanometrics, Inc. Ms. Tsingos was previously employed as a Chief Operating Financial Officer by Attest Systems, Inc., a Chief Financial Officer by Tavolo, Inc., and a Treasurer Vice President by Autodesk, Inc. She received her undergraduate degree from American University and an MBA from George Washington University. Giovanni Magni Giovanni Magni is Chief Strategy Officer Executive Vice President at Bio-Rad Laboratories, Inc. Andrew J. Last Andrew J. Last occupies the position of Chief Operating Officer Executive Vice President of Bio-Rad Laboratories, Inc. Dr. Last is also on the board of OncoCyte Corp. In his past career he was Chief Operating Officer of Intrexon Corp., VP-Global Marketing Strategic Planning at Becton, Dickinson Co. General Manager of PharMingen and Vice President-Global Strategic Marketing at BD Biosciences, Systems Reagents, Inc. (both are subsidiaries of Becton, Dickinson Co.), Chief Commercial Officer for Berkeley Lights, Inc., Chief Operating Officer Executive Vice President for Affymetrix, Inc., Director-Worldwide Business at Monsanto Co., Vice President GM-Gene Expression Business at Applera Corp., Director-Ortho Home Garden at The Solaris Group and Vice President General Manager at Applied Biosystems, Inc. Dr. Last received a doctorate and a graduate degree from Cranfield University and an undergraduate degree from the University of Leicester. John Hertia John Hertia is EVP President-Clinical Diagnostics Group at Bio-Rad Laboratories, Inc. He previously held the position of Manager-Worldwide Group Operations at Life Science Group, Inc. Gregory K. Hinckley Gregory K. Hinckley is on the board of Bio-Rad Laboratories, Inc., SI-BONE, Inc., Claremont McKenna College and Portland State University and Vice President at Portland Opera (Oregon). In the past he held the position of Chief Financial Officer of Bio-Rad Laboratories, Inc., President Chief Financial Officer of Mentor Graphics Corp., Chief Financial Officer for Crowley Maritime Corp., Chief Financial Officer Senior Vice President of VLSI Technology, Inc. and Principal at Raychem Corp. Mr. Hinckley received an undergraduate degree from Claremont McKenna College, an MBA from Harvard Business School and a graduate degree from the University of California San Diego. Norman D. Schwartz Currently, Norman D. Schwartz holds the position of Chairman, President Chief Executive Officer of Bio-Rad Laboratories, Inc. and Chairman at DiaMed France SA, Chairman for Bio-Rad Laboratories AB and Co-Managing Director at Bio-Rad Germany Holding GmbH (which are all subsidiaries of Bio-Rad Laboratories, Inc.). Norman D. Schwartz is also on the board of Diamed (G.B.) Ltd., Bio-Rad AbD Serotec Ltd., Bio-Rad Laboratories Ltd. and Immunsys, Inc. Mr. Schwartz previously occupied the position of Group Manager at Clinical Diagnostics, Inc. and Group Manager at Life Science Group, Inc. He received an undergraduate degree from San Francisco State University. Alice N. Schwartz Alice N. Schwartz founded Bio-Rad Laboratories, Inc. Ms. Schwartz is on the board of Bio-Rad Laboratories, Inc. In the past she held the position of Research Associate at the University of California. Arnold A. Pinkston Currently, Arnold A. Pinkston is Vice President General Counsel at Edwards Lifesciences Corp. He is also on the board of Bio-Rad Laboratories, Inc., MAP Pharmaceuticals, Inc. and Sustainability Accounting Standards Board. Mr. Pinkston previously occupied the position of Deputy General Counsel at Eli Lilly Co., Principal at McKesson Corp., Attorney at Orrick, Herrington Sutcliffe LLP, Secretary Chief Legal Officer of CoreLogic, Inc., Secretary, Senior Vice President General Counsel for Beckman Coulter, Inc., General Counsel of PCS Health Systems, Inc. and EVP, General Counsel Assistant Secretary at Allergan, Inc. Arnold A. Pinkston received a graduate degree from Yale Law School and an undergraduate degree from Yale College. Laura Rita Theil Founder of Jackryn France, Inc., Laura Rita Theil presently is President Chief Executive Officer for Jackryn Holdings, Inc. and Chief Executive Officer for Jackryn France, Inc. She is also on the board of 5 other companies. In her past career Ms. Theil occupied the position of Finance Director of Pieridae Energy Ltd., Assistant Director at Dresdner Kleinwort Wasserstein Ltd., Director-European Utilities at Schroder Salomon Smith Barney and Chartered Director at The Directors College. Laura Rita Theil received a graduate degree, an MBA and an undergraduate degree from the University of Ottawa. Ilan Daskal Ilan Daskal occupies the position of Chief Financial Officer Executive Vice President at Bio-Rad Laboratories, Inc. He is also on the board of CHiL Semiconductor Corp. In the past Mr. Daskal was Chief Financial Officer Executive Vice President for SunEdison, Inc., Vice President-Finance Business Administration at Infineon Technologies AG and Chief Financial Officer Executive Vice President for International Rectifier Corp. (a subsidiary of Infineon Technologies AG), President, Chief Executive Officer Director at TerraForm Power, Inc., Chief Financial Officer Executive Vice President of Cepheid, Chief Financial Officer at Lumileds LLC, Executive Vice President-Finance at Communication Solutions, Inc. and Chief Financial Officer at Aricent, Inc. Mr. Daskal received an undergraduate degree from Tel-Aviv University and a graduate degree from City University of New York. Timothy S. Ernst Timothy S. Ernst holds the position of Secretary, Executive VP General Counsel at Bio-Rad Laboratories, Inc. Mr. Ernst is also Member of The State Bar of California and Member of Association of Corporate Counsel. Mr. Ernst previously occupied the position of Secretary Senior Vice-President at Del Monte Foods Co., Associate General Counsel at California Hawaiian Sugar Co. and Secretary of Big Heart Pet Brands Corp. John Hertia John Hertia is EVP President-Clinical Diagnostics Group at Bio-Rad Laboratories, Inc. He previously held the position of Manager-Worldwide Group Operations at Life Science Group, Inc. Michael Crowley Michael Crowley is Executive VP-Global Commercial Operations at Bio-Rad Laboratories, Inc. Arnold A. Pinkston Currently, Arnold A. Pinkston is Vice President General Counsel at Edwards Lifesciences Corp. He is also on the board of Bio-Rad Laboratories, Inc., MAP Pharmaceuticals, Inc. and Sustainability Accounting Standards Board. Mr. Pinkston previously occupied the position of Deputy General Counsel at Eli Lilly Co., Principal at McKesson Corp., Attorney at Orrick, Herrington Sutcliffe LLP, Secretary Chief Legal Officer of CoreLogic, Inc., Secretary, Senior Vice President General Counsel for Beckman Coulter, Inc., General Counsel of PCS Health Systems, Inc. and EVP, General Counsel Assistant Secretary at Allergan, Inc. Arnold A. Pinkston received a graduate degree from Yale Law School and an undergraduate degree from Yale College. Melinda Litherland Melinda Litherland is on the board of Bio-Rad Laboratories, Inc. and Member of The American Institute of Certified Public Accountants. In her past career Ms. Litherland held the position of Partner at Deloitte Touche LLP.